According to the Market Research Blog, "the total U.S. weight loss market is estimated to have grown to a historic peak of ...

This is the fourth FDA-approved indication for Braftovi ... Victoza has been largely superseded by Novo Nordisk's once-weekly therapy Ozempic (semaglutide), with sales falling 41% in the first ...

Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...

After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin ...